March

March 26, 2015

Anti-cancer stem cell therapy: AMP-Activated Protein Kinase α 2 (AMPKα2) suppresses the expression of stem cell proteins Oct-4 and Sox-2 and inhibits cancer stem proliferation via up regulation of its target gene, 27/March/2015, 12.05 am

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, L., Anti-cancer stem cell therapy: AMP-Activated Protein Kinase α 2 (AMPKα2) suppresses the expression of stem cell proteins […]
March 26, 2015

T2DM drugs function as anti-metastatic agents: Acarbose, the widley used drug in the treatment of T2DM, suppresses the expression of actin-regulatory proteins FHOD1 and PPM1F and inhibits migration and invasion of metastatic cancer cells via up regulation of its target gene, 26/March/2015, 23.57

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, L., T2DM drugs function as anti-metastatic agents: Acarbose, the widley used drug in the treatment of […]
March 26, 2015

Anti-metastasis therapy: BMP4 inhibits invasion and metastasis by altering protein trafficking via up regulation of tumor suppressor PTPN14 (Pez), 26/March/2015, 23.39

A recent study from the From the Centre for Cancer Biology, an Alliance between SA Pathology and University of South Australia, Adelaide, South Australia 5000, Australia. Discipline of […]
March 26, 2015

Molecular therapy for Myocardial ischemia after myocardial infarction: Proto-oncogene c-Myc inhibits cardiac ischemia via up regulation of Aldehyde dehydrogenase 2 (ALDH2), 26/March/2015, 22.48

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, L., Molecular therapy for Myocardial ischemia after myocardial infarction: Proto-oncogene c-Myc inhibits cardiac ischemia via up […]